← Back to Search

Implantable Device

Beacon Aqueous Microshunt for Glaucoma (Beacon Trial)

N/A
Waitlist Available
Research Sponsored by MicroOptx
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Beacon Trial Summary

This trial will test a new type of glaucoma surgery to see if it is safe and effective.

Beacon Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness via Intraocular Pressure Reduction
Safety via Serious and Adverse Event Reporting
Secondary outcome measures
Kaplan-Meier Analysis of Failure
Mean Change from baseline in IOP
Number of topical IOP-lowering medications - Mean change from baseline
+4 more

Beacon Trial Design

1Treatment groups
Experimental Treatment
Group I: Beacon Aqueous MicroshuntExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

MicroOptxLead Sponsor
2 Previous Clinical Trials
18 Total Patients Enrolled
2 Trials studying Glaucoma
18 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025